nodes	percent_of_prediction	percent_of_DWPC	metapath
Terlipressin—Gonadorelin—Goserelin—breast cancer	0.623	1	CrCrCtD
Terlipressin—Atrial fibrillation—Capecitabine—breast cancer	0.000355	0.00163	CcSEcCtD
Terlipressin—Bradycardia—Irinotecan—breast cancer	0.000354	0.00163	CcSEcCtD
Terlipressin—Bradycardia—Mitoxantrone—breast cancer	0.000354	0.00163	CcSEcCtD
Terlipressin—Hypertension—Goserelin—breast cancer	0.000354	0.00163	CcSEcCtD
Terlipressin—Respiratory failure—Methotrexate—breast cancer	0.000352	0.00162	CcSEcCtD
Terlipressin—Malnutrition—Thiotepa—breast cancer	0.000351	0.00161	CcSEcCtD
Terlipressin—Diarrhoea—Letrozole—breast cancer	0.00035	0.00161	CcSEcCtD
Terlipressin—Diarrhoea—Anastrozole—breast cancer	0.00035	0.00161	CcSEcCtD
Terlipressin—Chest pain—Goserelin—breast cancer	0.000349	0.00161	CcSEcCtD
Terlipressin—Hyponatraemia—Docetaxel—breast cancer	0.000349	0.00161	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Goserelin—breast cancer	0.000347	0.00159	CcSEcCtD
Terlipressin—Vomiting—Ixabepilone—breast cancer	0.000346	0.00159	CcSEcCtD
Terlipressin—Cardiac failure—Capecitabine—breast cancer	0.000345	0.00159	CcSEcCtD
Terlipressin—Nausea—Exemestane—breast cancer	0.000342	0.00157	CcSEcCtD
Terlipressin—Headache—Ixabepilone—breast cancer	0.000341	0.00157	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Chlorambucil—breast cancer	0.00034	0.00156	CcSEcCtD
Terlipressin—Hyponatraemia—Capecitabine—breast cancer	0.000338	0.00155	CcSEcCtD
Terlipressin—Tachycardia—Melphalan—breast cancer	0.000335	0.00154	CcSEcCtD
Terlipressin—Skin disorder—Melphalan—breast cancer	0.000333	0.00153	CcSEcCtD
Terlipressin—Diarrhoea—Raloxifene—breast cancer	0.000333	0.00153	CcSEcCtD
Terlipressin—Diarrhoea—Idarubicin—breast cancer	0.000333	0.00153	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Doxorubicin—breast cancer	0.000331	0.00152	CcSEcCtD
Terlipressin—Skin exfoliation—Methotrexate—breast cancer	0.00033	0.00152	CcSEcCtD
Terlipressin—Nervous system disorder—Goserelin—breast cancer	0.000328	0.00151	CcSEcCtD
Terlipressin—Tachycardia—Goserelin—breast cancer	0.000327	0.0015	CcSEcCtD
Terlipressin—Vomiting—Letrozole—breast cancer	0.000326	0.0015	CcSEcCtD
Terlipressin—Vomiting—Anastrozole—breast cancer	0.000326	0.0015	CcSEcCtD
Terlipressin—Skin disorder—Goserelin—breast cancer	0.000325	0.00149	CcSEcCtD
Terlipressin—Nausea—Ixabepilone—breast cancer	0.000323	0.00149	CcSEcCtD
Terlipressin—Cardiac disorder—Irinotecan—breast cancer	0.000323	0.00148	CcSEcCtD
Terlipressin—Headache—Anastrozole—breast cancer	0.000321	0.00147	CcSEcCtD
Terlipressin—Headache—Letrozole—breast cancer	0.000321	0.00147	CcSEcCtD
Terlipressin—Hypertension—Vinorelbine—breast cancer	0.000317	0.00146	CcSEcCtD
Terlipressin—Angiopathy—Irinotecan—breast cancer	0.000316	0.00145	CcSEcCtD
Terlipressin—Cardiac disorder—Gemcitabine—breast cancer	0.000315	0.00145	CcSEcCtD
Terlipressin—Chest pain—Vinorelbine—breast cancer	0.000313	0.00144	CcSEcCtD
Terlipressin—Dyspnoea—Tamoxifen—breast cancer	0.000312	0.00144	CcSEcCtD
Terlipressin—Acute coronary syndrome—Paclitaxel—breast cancer	0.000312	0.00143	CcSEcCtD
Terlipressin—Abdominal pain—Chlorambucil—breast cancer	0.000311	0.00143	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—breast cancer	0.000311	0.00143	CcSEcCtD
Terlipressin—Myocardial infarction—Paclitaxel—breast cancer	0.00031	0.00142	CcSEcCtD
Terlipressin—Vomiting—Idarubicin—breast cancer	0.000309	0.00142	CcSEcCtD
Terlipressin—Vomiting—Raloxifene—breast cancer	0.000309	0.00142	CcSEcCtD
Terlipressin—Skin exfoliation—Epirubicin—breast cancer	0.000308	0.00142	CcSEcCtD
Terlipressin—Angiopathy—Gemcitabine—breast cancer	0.000308	0.00141	CcSEcCtD
Terlipressin—Pulmonary oedema—Methotrexate—breast cancer	0.000307	0.00141	CcSEcCtD
Terlipressin—Dyspnoea—Melphalan—breast cancer	0.000306	0.00141	CcSEcCtD
Terlipressin—Headache—Raloxifene—breast cancer	0.000304	0.0014	CcSEcCtD
Terlipressin—Headache—Idarubicin—breast cancer	0.000304	0.0014	CcSEcCtD
Terlipressin—Nausea—Anastrozole—breast cancer	0.000304	0.0014	CcSEcCtD
Terlipressin—Nausea—Letrozole—breast cancer	0.000304	0.0014	CcSEcCtD
Terlipressin—Hypertension—Thiotepa—breast cancer	0.000303	0.00139	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Tamoxifen—breast cancer	0.000303	0.00139	CcSEcCtD
Terlipressin—Dyspnoea—Goserelin—breast cancer	0.000298	0.00137	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—breast cancer	0.000297	0.00136	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Melphalan—breast cancer	0.000296	0.00136	CcSEcCtD
Terlipressin—Nervous system disorder—Vinorelbine—breast cancer	0.000294	0.00135	CcSEcCtD
Terlipressin—Tachycardia—Vinorelbine—breast cancer	0.000293	0.00135	CcSEcCtD
Terlipressin—Skin disorder—Vinorelbine—breast cancer	0.000291	0.00134	CcSEcCtD
Terlipressin—Bradycardia—Paclitaxel—breast cancer	0.000289	0.00133	CcSEcCtD
Terlipressin—Nausea—Idarubicin—breast cancer	0.000289	0.00133	CcSEcCtD
Terlipressin—Nausea—Raloxifene—breast cancer	0.000289	0.00133	CcSEcCtD
Terlipressin—Pulmonary oedema—Epirubicin—breast cancer	0.000288	0.00132	CcSEcCtD
Terlipressin—Skin exfoliation—Doxorubicin—breast cancer	0.000285	0.00131	CcSEcCtD
Terlipressin—Abdominal pain—Vinblastine—breast cancer	0.000285	0.00131	CcSEcCtD
Terlipressin—Nervous system disorder—Thiotepa—breast cancer	0.000281	0.00129	CcSEcCtD
Terlipressin—Tachycardia—Thiotepa—breast cancer	0.000279	0.00128	CcSEcCtD
Terlipressin—Skin disorder—Thiotepa—breast cancer	0.000278	0.00128	CcSEcCtD
Terlipressin—Abdominal pain—Tamoxifen—breast cancer	0.000277	0.00127	CcSEcCtD
Terlipressin—Diarrhoea—Chlorambucil—breast cancer	0.000269	0.00124	CcSEcCtD
Terlipressin—Dyspnoea—Vinorelbine—breast cancer	0.000267	0.00123	CcSEcCtD
Terlipressin—Pulmonary oedema—Doxorubicin—breast cancer	0.000266	0.00122	CcSEcCtD
Terlipressin—Abdominal pain—Goserelin—breast cancer	0.000265	0.00122	CcSEcCtD
Terlipressin—Acute coronary syndrome—Docetaxel—breast cancer	0.000264	0.00121	CcSEcCtD
Terlipressin—Cardiac disorder—Paclitaxel—breast cancer	0.000263	0.00121	CcSEcCtD
Terlipressin—Myocardial infarction—Docetaxel—breast cancer	0.000263	0.00121	CcSEcCtD
Terlipressin—Hypertension—Irinotecan—breast cancer	0.000262	0.0012	CcSEcCtD
Terlipressin—Hypertension—Mitoxantrone—breast cancer	0.000262	0.0012	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Vinorelbine—breast cancer	0.000259	0.00119	CcSEcCtD
Terlipressin—Chest pain—Mitoxantrone—breast cancer	0.000258	0.00119	CcSEcCtD
Terlipressin—Angiopathy—Paclitaxel—breast cancer	0.000257	0.00118	CcSEcCtD
Terlipressin—Acute coronary syndrome—Capecitabine—breast cancer	0.000256	0.00118	CcSEcCtD
Terlipressin—Hypertension—Gemcitabine—breast cancer	0.000255	0.00117	CcSEcCtD
Terlipressin—Myocardial infarction—Capecitabine—breast cancer	0.000254	0.00117	CcSEcCtD
Terlipressin—Chest pain—Gemcitabine—breast cancer	0.000251	0.00116	CcSEcCtD
Terlipressin—Hot flush—Epirubicin—breast cancer	0.000251	0.00115	CcSEcCtD
Terlipressin—Vomiting—Chlorambucil—breast cancer	0.00025	0.00115	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—breast cancer	0.000249	0.00115	CcSEcCtD
Terlipressin—Menopausal symptoms—Epirubicin—breast cancer	0.000249	0.00114	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Thiotepa—breast cancer	0.000247	0.00114	CcSEcCtD
Terlipressin—Malnutrition—Paclitaxel—breast cancer	0.000247	0.00114	CcSEcCtD
Terlipressin—Chest pain—Fluorouracil—breast cancer	0.000247	0.00114	CcSEcCtD
Terlipressin—Diarrhoea—Vinblastine—breast cancer	0.000247	0.00113	CcSEcCtD
Terlipressin—Nervous system disorder—Irinotecan—breast cancer	0.000242	0.00111	CcSEcCtD
Terlipressin—Tachycardia—Mitoxantrone—breast cancer	0.000241	0.00111	CcSEcCtD
Terlipressin—Cardiac failure—Epirubicin—breast cancer	0.00024	0.0011	CcSEcCtD
Terlipressin—Skin disorder—Mitoxantrone—breast cancer	0.00024	0.0011	CcSEcCtD
Terlipressin—Diarrhoea—Tamoxifen—breast cancer	0.00024	0.0011	CcSEcCtD
Terlipressin—Bradycardia—Capecitabine—breast cancer	0.000237	0.00109	CcSEcCtD
Terlipressin—Abdominal pain—Vinorelbine—breast cancer	0.000237	0.00109	CcSEcCtD
Terlipressin—Nervous system disorder—Gemcitabine—breast cancer	0.000236	0.00109	CcSEcCtD
Terlipressin—Hyponatraemia—Epirubicin—breast cancer	0.000235	0.00108	CcSEcCtD
Terlipressin—Diarrhoea—Melphalan—breast cancer	0.000235	0.00108	CcSEcCtD
Terlipressin—Skin disorder—Gemcitabine—breast cancer	0.000234	0.00108	CcSEcCtD
Terlipressin—Nausea—Chlorambucil—breast cancer	0.000234	0.00107	CcSEcCtD
Terlipressin—Nervous system disorder—Fluorouracil—breast cancer	0.000232	0.00107	CcSEcCtD
Terlipressin—Hot flush—Doxorubicin—breast cancer	0.000232	0.00107	CcSEcCtD
Terlipressin—Tachycardia—Fluorouracil—breast cancer	0.000231	0.00106	CcSEcCtD
Terlipressin—Menopausal symptoms—Doxorubicin—breast cancer	0.00023	0.00106	CcSEcCtD
Terlipressin—Vomiting—Vinblastine—breast cancer	0.000229	0.00105	CcSEcCtD
Terlipressin—Diarrhoea—Goserelin—breast cancer	0.000229	0.00105	CcSEcCtD
Terlipressin—Abdominal pain—Thiotepa—breast cancer	0.000226	0.00104	CcSEcCtD
Terlipressin—Headache—Vinblastine—breast cancer	0.000226	0.00104	CcSEcCtD
Terlipressin—Cardiac disorder—Docetaxel—breast cancer	0.000223	0.00103	CcSEcCtD
Terlipressin—Vomiting—Tamoxifen—breast cancer	0.000223	0.00102	CcSEcCtD
Terlipressin—Cardiac failure—Doxorubicin—breast cancer	0.000222	0.00102	CcSEcCtD
Terlipressin—Dyspnoea—Mitoxantrone—breast cancer	0.00022	0.00101	CcSEcCtD
Terlipressin—Dyspnoea—Irinotecan—breast cancer	0.00022	0.00101	CcSEcCtD
Terlipressin—Headache—Tamoxifen—breast cancer	0.00022	0.00101	CcSEcCtD
Terlipressin—Angiopathy—Docetaxel—breast cancer	0.000218	0.001	CcSEcCtD
Terlipressin—Vomiting—Melphalan—breast cancer	0.000218	0.001	CcSEcCtD
Terlipressin—Hyponatraemia—Doxorubicin—breast cancer	0.000218	0.001	CcSEcCtD
Terlipressin—Cardiac disorder—Capecitabine—breast cancer	0.000216	0.000994	CcSEcCtD
Terlipressin—Dyspnoea—Gemcitabine—breast cancer	0.000215	0.000987	CcSEcCtD
Terlipressin—Nausea—Vinblastine—breast cancer	0.000214	0.000985	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Irinotecan—breast cancer	0.000213	0.000981	CcSEcCtD
Terlipressin—Hypertension—Paclitaxel—breast cancer	0.000213	0.000981	CcSEcCtD
Terlipressin—Vomiting—Goserelin—breast cancer	0.000213	0.000978	CcSEcCtD
Terlipressin—Angiopathy—Capecitabine—breast cancer	0.000211	0.000972	CcSEcCtD
Terlipressin—Dyspnoea—Fluorouracil—breast cancer	0.000211	0.000971	CcSEcCtD
Terlipressin—Chest pain—Paclitaxel—breast cancer	0.00021	0.000967	CcSEcCtD
Terlipressin—Headache—Goserelin—breast cancer	0.00021	0.000964	CcSEcCtD
Terlipressin—Malnutrition—Docetaxel—breast cancer	0.000209	0.000963	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000209	0.00096	CcSEcCtD
Terlipressin—Nausea—Tamoxifen—breast cancer	0.000208	0.000957	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000208	0.000956	CcSEcCtD
Terlipressin—Diarrhoea—Vinorelbine—breast cancer	0.000205	0.000943	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000204	0.00094	CcSEcCtD
Terlipressin—Nausea—Melphalan—breast cancer	0.000204	0.000937	CcSEcCtD
Terlipressin—Malnutrition—Capecitabine—breast cancer	0.000203	0.000932	CcSEcCtD
Terlipressin—Nausea—Goserelin—breast cancer	0.000199	0.000914	CcSEcCtD
Terlipressin—Nervous system disorder—Paclitaxel—breast cancer	0.000198	0.000909	CcSEcCtD
Terlipressin—Tachycardia—Paclitaxel—breast cancer	0.000197	0.000905	CcSEcCtD
Terlipressin—Diarrhoea—Thiotepa—breast cancer	0.000196	0.000901	CcSEcCtD
Terlipressin—Skin disorder—Paclitaxel—breast cancer	0.000196	0.0009	CcSEcCtD
Terlipressin—Abdominal pain—Irinotecan—breast cancer	0.000195	0.000899	CcSEcCtD
Terlipressin—Abdominal pain—Mitoxantrone—breast cancer	0.000195	0.000899	CcSEcCtD
Terlipressin—Vomiting—Vinorelbine—breast cancer	0.000191	0.000876	CcSEcCtD
Terlipressin—Headache—Vinorelbine—breast cancer	0.000188	0.000863	CcSEcCtD
Terlipressin—Vomiting—Thiotepa—breast cancer	0.000182	0.000837	CcSEcCtD
Terlipressin—Hypertension—Docetaxel—breast cancer	0.000181	0.000831	CcSEcCtD
Terlipressin—Dyspnoea—Paclitaxel—breast cancer	0.00018	0.000826	CcSEcCtD
Terlipressin—Headache—Thiotepa—breast cancer	0.000179	0.000825	CcSEcCtD
Terlipressin—Chest pain—Docetaxel—breast cancer	0.000178	0.00082	CcSEcCtD
Terlipressin—Nausea—Vinorelbine—breast cancer	0.000178	0.000819	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000177	0.000814	CcSEcCtD
Terlipressin—Hypertension—Capecitabine—breast cancer	0.000175	0.000805	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000174	0.0008	CcSEcCtD
Terlipressin—Chest pain—Capecitabine—breast cancer	0.000173	0.000794	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000171	0.000788	CcSEcCtD
Terlipressin—Nausea—Thiotepa—breast cancer	0.00017	0.000782	CcSEcCtD
Terlipressin—Diarrhoea—Mitoxantrone—breast cancer	0.000169	0.000778	CcSEcCtD
Terlipressin—Diarrhoea—Irinotecan—breast cancer	0.000169	0.000778	CcSEcCtD
Terlipressin—Nervous system disorder—Docetaxel—breast cancer	0.000168	0.000771	CcSEcCtD
Terlipressin—Tachycardia—Docetaxel—breast cancer	0.000167	0.000767	CcSEcCtD
Terlipressin—Skin disorder—Docetaxel—breast cancer	0.000166	0.000763	CcSEcCtD
Terlipressin—Bradycardia—Epirubicin—breast cancer	0.000165	0.000759	CcSEcCtD
Terlipressin—Diarrhoea—Gemcitabine—breast cancer	0.000165	0.000758	CcSEcCtD
Terlipressin—Nervous system disorder—Capecitabine—breast cancer	0.000162	0.000746	CcSEcCtD
Terlipressin—Diarrhoea—Fluorouracil—breast cancer	0.000162	0.000745	CcSEcCtD
Terlipressin—Tachycardia—Capecitabine—breast cancer	0.000161	0.000742	CcSEcCtD
Terlipressin—Cardiac disorder—Methotrexate—breast cancer	0.000161	0.00074	CcSEcCtD
Terlipressin—Skin disorder—Capecitabine—breast cancer	0.000161	0.000739	CcSEcCtD
Terlipressin—Abdominal pain—Paclitaxel—breast cancer	0.000159	0.000733	CcSEcCtD
Terlipressin—Angiopathy—Methotrexate—breast cancer	0.000157	0.000723	CcSEcCtD
Terlipressin—Vomiting—Mitoxantrone—breast cancer	0.000157	0.000723	CcSEcCtD
Terlipressin—Vomiting—Irinotecan—breast cancer	0.000157	0.000723	CcSEcCtD
Terlipressin—Headache—Mitoxantrone—breast cancer	0.000155	0.000712	CcSEcCtD
Terlipressin—Headache—Irinotecan—breast cancer	0.000155	0.000712	CcSEcCtD
Terlipressin—Vomiting—Gemcitabine—breast cancer	0.000153	0.000704	CcSEcCtD
Terlipressin—Bradycardia—Doxorubicin—breast cancer	0.000153	0.000703	CcSEcCtD
Terlipressin—Dyspnoea—Docetaxel—breast cancer	0.000152	0.000701	CcSEcCtD
Terlipressin—Malnutrition—Methotrexate—breast cancer	0.000151	0.000694	CcSEcCtD
Terlipressin—Headache—Gemcitabine—breast cancer	0.000151	0.000694	CcSEcCtD
Terlipressin—Cardiac disorder—Epirubicin—breast cancer	0.000151	0.000692	CcSEcCtD
Terlipressin—Vomiting—Fluorouracil—breast cancer	0.000151	0.000692	CcSEcCtD
Terlipressin—Headache—Fluorouracil—breast cancer	0.000148	0.000682	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Docetaxel—breast cancer	0.000148	0.000678	CcSEcCtD
Terlipressin—Dyspnoea—Capecitabine—breast cancer	0.000148	0.000678	CcSEcCtD
Terlipressin—Angiopathy—Epirubicin—breast cancer	0.000147	0.000677	CcSEcCtD
Terlipressin—Nausea—Mitoxantrone—breast cancer	0.000147	0.000675	CcSEcCtD
Terlipressin—Nausea—Irinotecan—breast cancer	0.000147	0.000675	CcSEcCtD
Terlipressin—Nausea—Gemcitabine—breast cancer	0.000143	0.000658	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Capecitabine—breast cancer	0.000143	0.000657	CcSEcCtD
Terlipressin—Malnutrition—Epirubicin—breast cancer	0.000141	0.000649	CcSEcCtD
Terlipressin—Nausea—Fluorouracil—breast cancer	0.000141	0.000647	CcSEcCtD
Terlipressin—Cardiac disorder—Doxorubicin—breast cancer	0.000139	0.000641	CcSEcCtD
Terlipressin—Diarrhoea—Paclitaxel—breast cancer	0.000138	0.000634	CcSEcCtD
Terlipressin—Angiopathy—Doxorubicin—breast cancer	0.000136	0.000626	CcSEcCtD
Terlipressin—Abdominal pain—Docetaxel—breast cancer	0.000135	0.000621	CcSEcCtD
Terlipressin—Abdominal pain—Capecitabine—breast cancer	0.000131	0.000601	CcSEcCtD
Terlipressin—Malnutrition—Doxorubicin—breast cancer	0.000131	0.000601	CcSEcCtD
Terlipressin—Chest pain—Methotrexate—breast cancer	0.000128	0.000591	CcSEcCtD
Terlipressin—Vomiting—Paclitaxel—breast cancer	0.000128	0.000589	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000128	0.000587	CcSEcCtD
Terlipressin—Headache—Paclitaxel—breast cancer	0.000126	0.000581	CcSEcCtD
Terlipressin—Hypertension—Epirubicin—breast cancer	0.000122	0.000561	CcSEcCtD
Terlipressin—Nervous system disorder—Methotrexate—breast cancer	0.000121	0.000555	CcSEcCtD
Terlipressin—Chest pain—Epirubicin—breast cancer	0.00012	0.000553	CcSEcCtD
Terlipressin—Nausea—Paclitaxel—breast cancer	0.00012	0.000551	CcSEcCtD
Terlipressin—Skin disorder—Methotrexate—breast cancer	0.00012	0.00055	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000119	0.000549	CcSEcCtD
Terlipressin—Diarrhoea—Docetaxel—breast cancer	0.000117	0.000538	CcSEcCtD
Terlipressin—Diarrhoea—Capecitabine—breast cancer	0.000113	0.000521	CcSEcCtD
Terlipressin—Nervous system disorder—Epirubicin—breast cancer	0.000113	0.00052	CcSEcCtD
Terlipressin—Hypertension—Doxorubicin—breast cancer	0.000113	0.000519	CcSEcCtD
Terlipressin—Tachycardia—Epirubicin—breast cancer	0.000112	0.000517	CcSEcCtD
Terlipressin—Skin disorder—Epirubicin—breast cancer	0.000112	0.000515	CcSEcCtD
Terlipressin—Chest pain—Doxorubicin—breast cancer	0.000111	0.000512	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.00011	0.000508	CcSEcCtD
Terlipressin—Dyspnoea—Methotrexate—breast cancer	0.00011	0.000505	CcSEcCtD
Terlipressin—Vomiting—Docetaxel—breast cancer	0.000109	0.0005	CcSEcCtD
Terlipressin—Headache—Docetaxel—breast cancer	0.000107	0.000492	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Methotrexate—breast cancer	0.000106	0.000489	CcSEcCtD
Terlipressin—Vomiting—Capecitabine—breast cancer	0.000105	0.000484	CcSEcCtD
Terlipressin—Nervous system disorder—Doxorubicin—breast cancer	0.000105	0.000481	CcSEcCtD
Terlipressin—Tachycardia—Doxorubicin—breast cancer	0.000104	0.000479	CcSEcCtD
Terlipressin—Headache—Capecitabine—breast cancer	0.000104	0.000477	CcSEcCtD
Terlipressin—Skin disorder—Doxorubicin—breast cancer	0.000104	0.000476	CcSEcCtD
Terlipressin—Dyspnoea—Epirubicin—breast cancer	0.000103	0.000472	CcSEcCtD
Terlipressin—Nausea—Docetaxel—breast cancer	0.000102	0.000467	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Epirubicin—breast cancer	9.95e-05	0.000458	CcSEcCtD
Terlipressin—Nausea—Capecitabine—breast cancer	9.83e-05	0.000452	CcSEcCtD
Terlipressin—Abdominal pain—Methotrexate—breast cancer	9.74e-05	0.000448	CcSEcCtD
Terlipressin—Dyspnoea—Doxorubicin—breast cancer	9.51e-05	0.000437	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Doxorubicin—breast cancer	9.21e-05	0.000423	CcSEcCtD
Terlipressin—Abdominal pain—Epirubicin—breast cancer	9.11e-05	0.000419	CcSEcCtD
Terlipressin—Abdominal pain—Doxorubicin—breast cancer	8.43e-05	0.000388	CcSEcCtD
Terlipressin—Diarrhoea—Methotrexate—breast cancer	8.43e-05	0.000387	CcSEcCtD
Terlipressin—Diarrhoea—Epirubicin—breast cancer	7.89e-05	0.000363	CcSEcCtD
Terlipressin—Vomiting—Methotrexate—breast cancer	7.83e-05	0.00036	CcSEcCtD
Terlipressin—Headache—Methotrexate—breast cancer	7.72e-05	0.000355	CcSEcCtD
Terlipressin—Vomiting—Epirubicin—breast cancer	7.33e-05	0.000337	CcSEcCtD
Terlipressin—Nausea—Methotrexate—breast cancer	7.32e-05	0.000336	CcSEcCtD
Terlipressin—Diarrhoea—Doxorubicin—breast cancer	7.3e-05	0.000336	CcSEcCtD
Terlipressin—Headache—Epirubicin—breast cancer	7.22e-05	0.000332	CcSEcCtD
Terlipressin—Nausea—Epirubicin—breast cancer	6.85e-05	0.000315	CcSEcCtD
Terlipressin—Vomiting—Doxorubicin—breast cancer	6.78e-05	0.000312	CcSEcCtD
Terlipressin—Headache—Doxorubicin—breast cancer	6.68e-05	0.000307	CcSEcCtD
Terlipressin—Nausea—Doxorubicin—breast cancer	6.33e-05	0.000291	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—FGFR1—breast cancer	4.65e-05	0.000292	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HSP90AA1—breast cancer	4.62e-05	0.00029	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NOTCH2—breast cancer	4.62e-05	0.00029	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HSP90AA1—breast cancer	4.58e-05	0.000288	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NOTCH2—breast cancer	4.58e-05	0.000288	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CD—breast cancer	4.58e-05	0.000288	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HIF1A—breast cancer	4.58e-05	0.000288	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CD—breast cancer	4.55e-05	0.000286	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PRL—breast cancer	4.49e-05	0.000282	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AGTR1—breast cancer	4.49e-05	0.000282	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—LEP—breast cancer	4.47e-05	0.000281	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AGTR1—breast cancer	4.46e-05	0.00028	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PRL—breast cancer	4.46e-05	0.00028	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—STK11—breast cancer	4.43e-05	0.000278	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CAV1—breast cancer	4.43e-05	0.000278	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ADAM10—breast cancer	4.43e-05	0.000278	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ADAM10—breast cancer	4.39e-05	0.000276	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—STK11—breast cancer	4.39e-05	0.000276	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KDR—breast cancer	4.38e-05	0.000275	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PLG—breast cancer	4.38e-05	0.000275	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PLG—breast cancer	4.35e-05	0.000273	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—AKT2—breast cancer	4.33e-05	0.000272	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FGF10—breast cancer	4.31e-05	0.000271	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—AKT2—breast cancer	4.3e-05	0.00027	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FGF10—breast cancer	4.28e-05	0.000269	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ESR1—breast cancer	4.27e-05	0.000268	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—FN1—breast cancer	4.21e-05	0.000265	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NFKBIA—breast cancer	4.16e-05	0.000262	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CD—breast cancer	4.16e-05	0.000261	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PDGFA—breast cancer	4.16e-05	0.000261	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CD—breast cancer	4.13e-05	0.000259	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PDGFA—breast cancer	4.13e-05	0.000259	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NOTCH1—breast cancer	4.12e-05	0.000259	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TGFBR2—breast cancer	4.1e-05	0.000257	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TGFBR2—breast cancer	4.07e-05	0.000256	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—APC—breast cancer	4.03e-05	0.000253	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CG—breast cancer	4.03e-05	0.000253	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KIT—breast cancer	4.03e-05	0.000253	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ITPR1—breast cancer	4.03e-05	0.000253	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MMP3—breast cancer	4e-05	0.000252	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—STAT5A—breast cancer	4e-05	0.000252	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ERBB4—breast cancer	4e-05	0.000252	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ITPR1—breast cancer	4e-05	0.000251	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CB—breast cancer	3.99e-05	0.000251	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—EGF—breast cancer	3.99e-05	0.00025	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ERBB4—breast cancer	3.97e-05	0.00025	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—STAT5A—breast cancer	3.97e-05	0.00025	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MMP3—breast cancer	3.97e-05	0.00025	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CB—breast cancer	3.96e-05	0.000249	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SMAD4—breast cancer	3.88e-05	0.000244	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—MAPK3—breast cancer	3.86e-05	0.000243	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IGF1R—breast cancer	3.85e-05	0.000242	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SMAD4—breast cancer	3.85e-05	0.000242	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CXCL8—breast cancer	3.84e-05	0.000241	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IGF1R—breast cancer	3.83e-05	0.00024	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CXCL8—breast cancer	3.81e-05	0.000239	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—BRAF—breast cancer	3.79e-05	0.000238	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HES1—breast cancer	3.79e-05	0.000238	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PLA2G4A—breast cancer	3.76e-05	0.000237	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NCOR1—breast cancer	3.76e-05	0.000237	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HES1—breast cancer	3.76e-05	0.000236	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PLA2G4A—breast cancer	3.74e-05	0.000235	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NCOR1—breast cancer	3.74e-05	0.000235	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CSF2—breast cancer	3.72e-05	0.000234	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FGF1—breast cancer	3.72e-05	0.000234	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—RAF1—breast cancer	3.71e-05	0.000233	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CSF2—breast cancer	3.7e-05	0.000232	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FGF1—breast cancer	3.7e-05	0.000232	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NRG1—breast cancer	3.69e-05	0.000232	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IGF1—breast cancer	3.69e-05	0.000232	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—AKT2—breast cancer	3.69e-05	0.000232	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—RAF1—breast cancer	3.69e-05	0.000232	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—EGFR—breast cancer	3.67e-05	0.000231	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—H2AFX—breast cancer	3.67e-05	0.00023	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NRG1—breast cancer	3.67e-05	0.00023	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—IL2—breast cancer	3.67e-05	0.00023	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—E2F1—breast cancer	3.64e-05	0.000229	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—H2AFX—breast cancer	3.64e-05	0.000229	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—IL2—breast cancer	3.64e-05	0.000229	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CB—breast cancer	3.63e-05	0.000228	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—E2F1—breast cancer	3.62e-05	0.000227	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CB—breast cancer	3.6e-05	0.000226	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CD—breast cancer	3.54e-05	0.000223	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CA—breast cancer	3.51e-05	0.000221	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SERPINE1—breast cancer	3.51e-05	0.00022	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SPP1—breast cancer	3.5e-05	0.00022	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CXCL8—breast cancer	3.48e-05	0.000219	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SPP1—breast cancer	3.47e-05	0.000218	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—KRAS—breast cancer	3.47e-05	0.000218	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ERBB3—breast cancer	3.46e-05	0.000217	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CXCL8—breast cancer	3.46e-05	0.000217	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FGFR2—breast cancer	3.46e-05	0.000217	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ERBB3—breast cancer	3.44e-05	0.000216	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FGFR2—breast cancer	3.43e-05	0.000216	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NOS3—breast cancer	3.35e-05	0.00021	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL2—breast cancer	3.33e-05	0.000209	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TERT—breast cancer	3.32e-05	0.000208	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL2—breast cancer	3.31e-05	0.000208	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TERT—breast cancer	3.29e-05	0.000207	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FGFR1—breast cancer	3.22e-05	0.000202	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FGFR1—breast cancer	3.2e-05	0.000201	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CA—breast cancer	3.19e-05	0.0002	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MDM2—breast cancer	3.18e-05	0.0002	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HIF1A—breast cancer	3.17e-05	0.000199	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—RAF1—breast cancer	3.16e-05	0.000199	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—RELA—breast cancer	3.15e-05	0.000198	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HIF1A—breast cancer	3.15e-05	0.000198	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ERBB2—breast cancer	3.13e-05	0.000197	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—LEP—breast cancer	3.1e-05	0.000195	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MTOR—breast cancer	3.09e-05	0.000194	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CB—breast cancer	3.09e-05	0.000194	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—LEP—breast cancer	3.07e-05	0.000193	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CAV1—breast cancer	3.07e-05	0.000193	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CAV1—breast cancer	3.05e-05	0.000191	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KDR—breast cancer	3.03e-05	0.000191	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KDR—breast cancer	3.01e-05	0.000189	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CXCL8—breast cancer	2.97e-05	0.000187	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ESR1—breast cancer	2.96e-05	0.000186	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—HRAS—breast cancer	2.95e-05	0.000185	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ESR1—breast cancer	2.94e-05	0.000184	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FN1—breast cancer	2.92e-05	0.000184	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CDKN1B—breast cancer	2.9e-05	0.000182	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FN1—breast cancer	2.9e-05	0.000182	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NFKBIA—breast cancer	2.89e-05	0.000181	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—AKT1—breast cancer	2.87e-05	0.00018	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NFKBIA—breast cancer	2.87e-05	0.00018	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NOTCH1—breast cancer	2.86e-05	0.00018	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CASP3—breast cancer	2.84e-05	0.000179	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NOTCH1—breast cancer	2.84e-05	0.000178	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL2—breast cancer	2.84e-05	0.000178	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL6—breast cancer	2.82e-05	0.000177	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CG—breast cancer	2.79e-05	0.000176	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KIT—breast cancer	2.79e-05	0.000176	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—APC—breast cancer	2.79e-05	0.000176	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CG—breast cancer	2.77e-05	0.000174	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KIT—breast cancer	2.77e-05	0.000174	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—APC—breast cancer	2.77e-05	0.000174	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCND1—breast cancer	2.77e-05	0.000174	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EGF—breast cancer	2.76e-05	0.000174	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—JUN—breast cancer	2.76e-05	0.000173	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EGF—breast cancer	2.74e-05	0.000172	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CTNNB1—breast cancer	2.74e-05	0.000172	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MMP9—breast cancer	2.69e-05	0.000169	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—MAPK3—breast cancer	2.68e-05	0.000168	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CDKN1A—breast cancer	2.68e-05	0.000168	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PTEN—breast cancer	2.67e-05	0.000168	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—MAPK3—breast cancer	2.66e-05	0.000167	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—BRAF—breast cancer	2.63e-05	0.000165	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MAPK8—breast cancer	2.61e-05	0.000164	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—BRAF—breast cancer	2.61e-05	0.000164	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—AKT1—breast cancer	2.6e-05	0.000164	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IGF1—breast cancer	2.56e-05	0.000161	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AKT2—breast cancer	2.56e-05	0.000161	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—EGFR—breast cancer	2.55e-05	0.00016	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IGF1—breast cancer	2.54e-05	0.00016	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AKT2—breast cancer	2.54e-05	0.00016	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—EGFR—breast cancer	2.53e-05	0.000159	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SRC—breast cancer	2.48e-05	0.000156	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CD—breast cancer	2.46e-05	0.000154	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CD—breast cancer	2.44e-05	0.000153	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CA—breast cancer	2.43e-05	0.000153	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SERPINE1—breast cancer	2.43e-05	0.000153	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CA—breast cancer	2.42e-05	0.000152	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SERPINE1—breast cancer	2.41e-05	0.000152	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—VEGFA—breast cancer	2.41e-05	0.000152	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—KRAS—breast cancer	2.41e-05	0.000151	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—KRAS—breast cancer	2.39e-05	0.00015	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—STAT3—breast cancer	2.39e-05	0.00015	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NOS3—breast cancer	2.32e-05	0.000146	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NOS3—breast cancer	2.3e-05	0.000145	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MAPK3—breast cancer	2.28e-05	0.000143	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MYC—breast cancer	2.22e-05	0.000139	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TGFB1—breast cancer	2.21e-05	0.000139	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CA—breast cancer	2.21e-05	0.000139	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MDM2—breast cancer	2.2e-05	0.000138	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CA—breast cancer	2.19e-05	0.000138	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—RAF1—breast cancer	2.19e-05	0.000138	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MDM2—breast cancer	2.19e-05	0.000137	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—RELA—breast cancer	2.18e-05	0.000137	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—RAF1—breast cancer	2.18e-05	0.000137	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ERBB2—breast cancer	2.17e-05	0.000136	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—EGFR—breast cancer	2.17e-05	0.000136	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—RELA—breast cancer	2.17e-05	0.000136	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ERBB2—breast cancer	2.15e-05	0.000135	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MTOR—breast cancer	2.14e-05	0.000135	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CB—breast cancer	2.14e-05	0.000135	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MTOR—breast cancer	2.13e-05	0.000134	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CB—breast cancer	2.13e-05	0.000134	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CXCL8—breast cancer	2.06e-05	0.000129	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KRAS—breast cancer	2.05e-05	0.000129	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—HRAS—breast cancer	2.04e-05	0.000128	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CXCL8—breast cancer	2.04e-05	0.000128	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—HRAS—breast cancer	2.03e-05	0.000128	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CDKN1B—breast cancer	2.01e-05	0.000126	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CDKN1B—breast cancer	2e-05	0.000125	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—AKT1—breast cancer	1.99e-05	0.000125	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—AKT1—breast cancer	1.97e-05	0.000124	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CASP3—breast cancer	1.97e-05	0.000124	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL2—breast cancer	1.97e-05	0.000124	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL6—breast cancer	1.96e-05	0.000123	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CASP3—breast cancer	1.96e-05	0.000123	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL2—breast cancer	1.95e-05	0.000123	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL6—breast cancer	1.94e-05	0.000122	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCND1—breast cancer	1.92e-05	0.00012	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—JUN—breast cancer	1.91e-05	0.00012	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCND1—breast cancer	1.9e-05	0.00012	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—JUN—breast cancer	1.9e-05	0.000119	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CTNNB1—breast cancer	1.9e-05	0.000119	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CTNNB1—breast cancer	1.89e-05	0.000118	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CA—breast cancer	1.88e-05	0.000118	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MMP9—breast cancer	1.86e-05	0.000117	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CDKN1A—breast cancer	1.85e-05	0.000117	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTEN—breast cancer	1.85e-05	0.000116	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MMP9—breast cancer	1.85e-05	0.000116	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CDKN1A—breast cancer	1.84e-05	0.000116	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTEN—breast cancer	1.84e-05	0.000115	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TP53—breast cancer	1.82e-05	0.000114	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MAPK8—breast cancer	1.81e-05	0.000114	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—AKT1—breast cancer	1.81e-05	0.000113	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MAPK8—breast cancer	1.8e-05	0.000113	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—AKT1—breast cancer	1.79e-05	0.000113	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HRAS—breast cancer	1.74e-05	0.000109	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SRC—breast cancer	1.72e-05	0.000108	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SRC—breast cancer	1.7e-05	0.000107	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—VEGFA—breast cancer	1.67e-05	0.000105	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL6—breast cancer	1.67e-05	0.000105	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—VEGFA—breast cancer	1.66e-05	0.000104	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—STAT3—breast cancer	1.66e-05	0.000104	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—STAT3—breast cancer	1.64e-05	0.000103	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MAPK3—breast cancer	1.58e-05	9.94e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MAPK3—breast cancer	1.57e-05	9.86e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—AKT1—breast cancer	1.54e-05	9.67e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MYC—breast cancer	1.54e-05	9.66e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TGFB1—breast cancer	1.53e-05	9.64e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MYC—breast cancer	1.53e-05	9.59e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TGFB1—breast cancer	1.52e-05	9.57e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EGFR—breast cancer	1.5e-05	9.45e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EGFR—breast cancer	1.49e-05	9.38e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KRAS—breast cancer	1.42e-05	8.93e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KRAS—breast cancer	1.41e-05	8.86e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CA—breast cancer	1.31e-05	8.2e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CA—breast cancer	1.3e-05	8.14e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TP53—breast cancer	1.26e-05	7.94e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TP53—breast cancer	1.25e-05	7.88e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HRAS—breast cancer	1.21e-05	7.59e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HRAS—breast cancer	1.2e-05	7.54e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL6—breast cancer	1.16e-05	7.26e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL6—breast cancer	1.15e-05	7.21e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AKT1—breast cancer	1.07e-05	6.7e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AKT1—breast cancer	1.06e-05	6.65e-05	CbGpPWpGaD
